HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

Andrew I. Flyak, Stormy Ruiz, Michelle D. Colbert, Tiffany Luong, James E. Crowe, Justin Bailey, Pamela J. Bjorkman

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) vaccine efforts are hampered by the extensive genetic diversity of HCV envelope glycoproteins E1 and E2. Structures of broadly neutralizing antibodies (bNAbs) (e.g., HEPC3, HEPC74) isolated from individuals who spontaneously cleared HCV infection facilitate immunogen design to elicit antibodies against multiple HCV variants. However, challenges in expressing HCV glycoproteins previously limited bNAb-HCV structures to complexes with truncated E2 cores. Here we describe crystal structures of full-length E2 ectodomain complexes with HEPC3 and HEPC74, revealing lock-and-key antibody-antigen interactions, E2 regions (including a target of immunogen design) that were truncated or disordered in E2 cores, and an antibody CDRH3 disulfide motif that exhibits common interactions with a conserved epitope despite different bNAb-E2 binding orientations. The structures display unusual features relevant to common genetic signatures of HCV bNAbs and demonstrate extraordinary plasticity in antibody-antigen interactions. In addition, E2 variants that bind HEPC3/HEPC74-like germline precursors may represent candidate vaccine immunogens. Flyak et al. present the structures of full-length E2 ectodomains of HCV bound to two broadly neutralizing antibodies isolated from individuals who spontaneously cleared infection. The structures illustrate shared genetic signatures and a common mode of antigen recognition using CDRH3s. These results demonstrate antibody plasticity and inform lineage-targeted immunogen design.

Original languageEnglish (US)
Pages (from-to)703-716.e3
JournalCell Host and Microbe
Volume24
Issue number5
DOIs
StatePublished - Nov 14 2018

Fingerprint

Neutralizing Antibodies
Hepacivirus
Disulfides
Glycoproteins
Vaccines
Antibodies
Antigens
Viral Structures
Virus Diseases
Epitopes
Infection

Keywords

  • broadly neutralizing antibodies
  • disulfide bond
  • E2
  • epitope
  • glycoprotein
  • HCV
  • structure

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology

Cite this

HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. / Flyak, Andrew I.; Ruiz, Stormy; Colbert, Michelle D.; Luong, Tiffany; Crowe, James E.; Bailey, Justin; Bjorkman, Pamela J.

In: Cell Host and Microbe, Vol. 24, No. 5, 14.11.2018, p. 703-716.e3.

Research output: Contribution to journalArticle

Flyak, Andrew I. ; Ruiz, Stormy ; Colbert, Michelle D. ; Luong, Tiffany ; Crowe, James E. ; Bailey, Justin ; Bjorkman, Pamela J. / HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. In: Cell Host and Microbe. 2018 ; Vol. 24, No. 5. pp. 703-716.e3.
@article{791601d6b050401c996d8e670f51cec6,
title = "HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design",
abstract = "Hepatitis C virus (HCV) vaccine efforts are hampered by the extensive genetic diversity of HCV envelope glycoproteins E1 and E2. Structures of broadly neutralizing antibodies (bNAbs) (e.g., HEPC3, HEPC74) isolated from individuals who spontaneously cleared HCV infection facilitate immunogen design to elicit antibodies against multiple HCV variants. However, challenges in expressing HCV glycoproteins previously limited bNAb-HCV structures to complexes with truncated E2 cores. Here we describe crystal structures of full-length E2 ectodomain complexes with HEPC3 and HEPC74, revealing lock-and-key antibody-antigen interactions, E2 regions (including a target of immunogen design) that were truncated or disordered in E2 cores, and an antibody CDRH3 disulfide motif that exhibits common interactions with a conserved epitope despite different bNAb-E2 binding orientations. The structures display unusual features relevant to common genetic signatures of HCV bNAbs and demonstrate extraordinary plasticity in antibody-antigen interactions. In addition, E2 variants that bind HEPC3/HEPC74-like germline precursors may represent candidate vaccine immunogens. Flyak et al. present the structures of full-length E2 ectodomains of HCV bound to two broadly neutralizing antibodies isolated from individuals who spontaneously cleared infection. The structures illustrate shared genetic signatures and a common mode of antigen recognition using CDRH3s. These results demonstrate antibody plasticity and inform lineage-targeted immunogen design.",
keywords = "broadly neutralizing antibodies, disulfide bond, E2, epitope, glycoprotein, HCV, structure",
author = "Flyak, {Andrew I.} and Stormy Ruiz and Colbert, {Michelle D.} and Tiffany Luong and Crowe, {James E.} and Justin Bailey and Bjorkman, {Pamela J.}",
year = "2018",
month = "11",
day = "14",
doi = "10.1016/j.chom.2018.10.009",
language = "English (US)",
volume = "24",
pages = "703--716.e3",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

AU - Flyak, Andrew I.

AU - Ruiz, Stormy

AU - Colbert, Michelle D.

AU - Luong, Tiffany

AU - Crowe, James E.

AU - Bailey, Justin

AU - Bjorkman, Pamela J.

PY - 2018/11/14

Y1 - 2018/11/14

N2 - Hepatitis C virus (HCV) vaccine efforts are hampered by the extensive genetic diversity of HCV envelope glycoproteins E1 and E2. Structures of broadly neutralizing antibodies (bNAbs) (e.g., HEPC3, HEPC74) isolated from individuals who spontaneously cleared HCV infection facilitate immunogen design to elicit antibodies against multiple HCV variants. However, challenges in expressing HCV glycoproteins previously limited bNAb-HCV structures to complexes with truncated E2 cores. Here we describe crystal structures of full-length E2 ectodomain complexes with HEPC3 and HEPC74, revealing lock-and-key antibody-antigen interactions, E2 regions (including a target of immunogen design) that were truncated or disordered in E2 cores, and an antibody CDRH3 disulfide motif that exhibits common interactions with a conserved epitope despite different bNAb-E2 binding orientations. The structures display unusual features relevant to common genetic signatures of HCV bNAbs and demonstrate extraordinary plasticity in antibody-antigen interactions. In addition, E2 variants that bind HEPC3/HEPC74-like germline precursors may represent candidate vaccine immunogens. Flyak et al. present the structures of full-length E2 ectodomains of HCV bound to two broadly neutralizing antibodies isolated from individuals who spontaneously cleared infection. The structures illustrate shared genetic signatures and a common mode of antigen recognition using CDRH3s. These results demonstrate antibody plasticity and inform lineage-targeted immunogen design.

AB - Hepatitis C virus (HCV) vaccine efforts are hampered by the extensive genetic diversity of HCV envelope glycoproteins E1 and E2. Structures of broadly neutralizing antibodies (bNAbs) (e.g., HEPC3, HEPC74) isolated from individuals who spontaneously cleared HCV infection facilitate immunogen design to elicit antibodies against multiple HCV variants. However, challenges in expressing HCV glycoproteins previously limited bNAb-HCV structures to complexes with truncated E2 cores. Here we describe crystal structures of full-length E2 ectodomain complexes with HEPC3 and HEPC74, revealing lock-and-key antibody-antigen interactions, E2 regions (including a target of immunogen design) that were truncated or disordered in E2 cores, and an antibody CDRH3 disulfide motif that exhibits common interactions with a conserved epitope despite different bNAb-E2 binding orientations. The structures display unusual features relevant to common genetic signatures of HCV bNAbs and demonstrate extraordinary plasticity in antibody-antigen interactions. In addition, E2 variants that bind HEPC3/HEPC74-like germline precursors may represent candidate vaccine immunogens. Flyak et al. present the structures of full-length E2 ectodomains of HCV bound to two broadly neutralizing antibodies isolated from individuals who spontaneously cleared infection. The structures illustrate shared genetic signatures and a common mode of antigen recognition using CDRH3s. These results demonstrate antibody plasticity and inform lineage-targeted immunogen design.

KW - broadly neutralizing antibodies

KW - disulfide bond

KW - E2

KW - epitope

KW - glycoprotein

KW - HCV

KW - structure

UR - http://www.scopus.com/inward/record.url?scp=85055801752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055801752&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2018.10.009

DO - 10.1016/j.chom.2018.10.009

M3 - Article

C2 - 30439340

AN - SCOPUS:85055801752

VL - 24

SP - 703-716.e3

JO - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

IS - 5

ER -